Related Experiment Video
Updated: Aug 6, 2026

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
Published on: January 5, 2021
How hypoxia and mechanics drive lung cancer progression
Meghana Kasturi1, Caymen M Novak1
1Bioengineering Program, Department of Mechanical Engineering, University of Michigan Dearborn, 4901 Evergreen Road, Dearborn, MI 48128, United States.
Hypoxia and extracellular matrix (ECM) stiffness are key in lung cancer progression. Understanding their combined effects is crucial for developing better experimental models and therapies for lung cancer.
Area of Science:
- Biophysics
- Cancer Biology
- Tumor Microenvironment
Background:
- Hypoxia and increased tissue stiffness are hallmarks of the lung tumor microenvironment.
- These factors independently promote cancer progression, therapy resistance, and metastasis.
- The interaction between hypoxia and ECM stiffness in lung cancer remains poorly understood.
Purpose of the Study:
- To synthesize current literature on the individual and combined roles of hypoxia and ECM stiffness in lung tumor progression.
- To evaluate existing in vitro models for studying these combined cues.
- To guide the development of advanced experimental models for lung cancer research.
Main Methods:
- Literature review of cellular and molecular mechanisms.
- Analysis of existing in vitro lung tumor microenvironment models.
- Discussion of emerging strategies for next-generation model systems.
Main Results:
- Hypoxic signaling and matrix stiffening arise from disrupted vascularization, proliferation, and ECM remodeling.
- These processes converge to influence cancer cell signaling, invasion, and treatment response.
- Current in vitro models have limitations in recapitulating combined microenvironmental cues.
Conclusions:
- There is a critical need for experimental models that capture the dynamic crosstalk between hypoxia and ECM stiffness.
- Advancing these models is essential for a better understanding of lung cancer mechanobiology.
- More predictive in vitro platforms will inform future therapeutic strategies against lung cancer.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply
The Tumor Microenvironment
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
